• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Joseph B. Stanford, MD, MSPH

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
5 4.9 out of 5 Patient Rating

Languages Spoken: English, German

Joseph B. Stanford, MD, MSPH, CFCMC, focuses his practice on restorative reproductive medicine (natural procreative technology) for infertility, miscarriage, and treating women’s health conditions without using artificial hormones. He also has a particular interests in polycystic ovarian syndrome, endometriosis, premenstrual syndrome, natural family planning and menopause. He is a certified FertilityCare Medical Consultant through the American Academy of FertilityCare Professionals. He received his medical degree from the University of Minnesota Medical School and completed residency training in family medicine and a master’s degree in public health at the University of Missouri-Columbia. He is board certified in family medicine, and a Fellow of the American Academy of Family Physicians. In his leisure time, Dr. Stanford enjoys spending time outdoors with his family. He accepts most insurance plans.

Clinical Locations

South Jordan Health Center

801-213-4500

5126 West Daybreak Parkway
South Jordan, UT  84009
Map

Specialties

  • Women's Health
  • Polycystic Ovary Syndrome
  • Telemedicine
  • Women and Children's Health
  • Natural Infertility
  • Restorative Reproductive Medicine

Board Certification and Academic Information

Academic Departments Family & Preventive Medicine - Professor
Obstetrics/Gynecology - Adjunct Professor
Pediatrics - Adjunct Professor
Academic Divisions General OB/GYN
Pediatric Administration
Public Health
Board Certification American Board of Family Medicine

Patient Rating

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Learn About Our Survey

Likelihood of recommending care provider

5.0/ 5

Care provider's explanation of condition/problem

4.8/ 5

Care provider's effort to include me in decisions

4.9/ 5

Wait time at clinic

4.5/ 5

Care provider's concern for questions & worries

4.9/ 5

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

UofU Patient June 06, 2021
SOUTH JORDAN HEALTH CENTER

5 out of 5 stars

Doctor Stanford is phenomenal. I would recommend him to all my infertile friends

UofU Patient May 24, 2021
SOUTH JORDAN HEALTH CENTER

5 out of 5 stars

I feel that Dr. Stanford looks at a bigger picture of health that actually treats your condition.

UofU Patient February 04, 2021
SOUTH JORDAN HEALTH CENTER

5 out of 5 stars

very good

UofU Patient November 25, 2020
SOUTH JORDAN HEALTH CENTER

5 out of 5 stars

Dr Stanford and his staff have been excellent at responding to my questions in a timely manner. I really appreciate how thorough he is during my appointments!

UofU Patient October 06, 2020
SOUTH JORDAN HEALTH CENTER

5 out of 5 stars

Dr Stanford was amazing! So thorough and caring.

Joseph B. Stanford, MD, MSPH, CFCMC, focuses his practice on restorative reproductive medicine (natural procreative technology) for infertility, miscarriage, and treating women’s health conditions without using artificial hormones. He also has a particular interests in polycystic ovarian syndrome, endometriosis, premenstrual syndrome, natural family planning and menopause. He is a certified FertilityCare Medical Consultant through the American Academy of FertilityCare Professionals. He received his medical degree from the University of Minnesota Medical School and completed residency training in family medicine and a master’s degree in public health at the University of Missouri-Columbia. He is board certified in family medicine, and a Fellow of the American Academy of Family Physicians. In his leisure time, Dr. Stanford enjoys spending time outdoors with his family. He accepts most insurance plans.

Academic Locations

Research Statement

I seek to understand and improve the impact of reproductive health on child health and development. Since 1991, I have conducted research in natural family planning, natural procreative technology, reproductive epidemiology, and life course epidemiology, including serving as principal investigator or co-investigator for five preconception cohort studies. I am currently principal investigator for the Utah Children's Project, a cohort to investigate child health outcomes in relation to early life exposures (back to conception) and genetics; and one of the principal investigators for the participation of UCP in the NIH Environmental influences and Child Health Outcomes (ECHO) consortium. I am also working on international practice-based research for restorative reproductive medicine- a primary approach to infertility that empowers couples, has cumulative live birth rates comparable to other treatments, and has much lower rates of perinatal and neonatal morbidity and lower cost.

Board Certification and Academic Information

Academic Departments Family & Preventive Medicine - Professor
Obstetrics/Gynecology - Adjunct Professor
Pediatrics - Adjunct Professor
Academic Divisions General OB/GYN
Pediatric Administration
Public Health
Board Certification American Board of Family Medicine

Research Interests

  • Reproductive Medicine
  • Epidemiologic Research Design
  • Epidemiology
  • Epidemiologic Methods
  • Life Course and Health Outcome
  • Child Development
  • Disorders of Environmental Origin
  • Fertility
  • Clinical Infertility
  • Infertility
  • Infertility, Female
  • Male Infertility
  • Restorative Reproductive Medicine
  • Fertility Awareness

Education History

Fellowship University of Missouri Health Sciences Center
Family & Community Medicine
Fellow, 1993
Graduate Training University of Missouri - Columbia
Public Health
M.S.P.H., 1993
Chief Resident University of Missouri Health Sciences Center
Family & Community Medicine
Chief Resident, 1991
Residency University of Missouri Health Sciences Center
Family & Community Medicine
Resident, 1990
Internship University of Missouri Health Sciences Center
Medicine
Intern, 1989
Professional Medical University of Minnesota
Medicine
M.D., 1988
Undergraduate Minnesota State University
Chemistry
B.A., 1984
Undergraduate University of Utah

, 1980

Selected Publications - Journal Articles

Journal Article

  1. Dawood FS, Porucznik CA, Veguilla V, Stanford JB, Duque J, Rolfes MA, Dixon A, Thind P, Hacker E, Castro MJE, Jeddy Z, Daugherty M, Altunkaynak K, Hunt DR, Kattel U, Meece J, Stockwell M (2021). Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York. JAMA Pediatr.
  2. Stratakis N, Garcia E, Chandran A, Hsu T, Alshawabkeh A, Aris IM, Aschner JL, Breton C, Burbank A, Camargo CA Jr, Carroll KN, Chen Z, Claud EC, Dabelea D, Dunlop AL, Elliott AJ, Ferrara A, Ganiban JM, Gern JE, Gold DR, Gower WA, Hertz-Picciotto I, Karagas MR, Karr CJ, Lester B, Leve LD, Litonjua AA, Ludena Y, McEvoy CT, Miller RL, Mueller NT, OConnor TG, Oken E, OShea TM, Perera F, Stanford JB, Rivera-Spoljaric K, Rundle A, Trasande L, Wright RJ, Zhang Y, Zhu Y, Berhane K, Gilliland F, Chatzi L, program collaborators for Environmental influences on Child Health Outcomes (2021). The Role of Childhood Asthma in Obesity Development: A Nationwide U.S. Multi-cohort Study. Epidemiology.
  3. Stanford JB, Carpentier PA, Meier BL, Rollo M, Tingey B (2021). Restorative reproductive medicine for infertility in two family medicine clinics in New England, an observational study. BMC Pregnancy Childbirth, 21(1), 495.
  4. Najmabadi S, Schliep KC, Simonsen SE, Porucznik CA, Egger MJ, Stanford JB (2020). Cervical mucus patterns and the fertile window in women without known subfertility: a pooled analysis of three cohorts. Hum Reprod, 36(7), 1784-1795.
  5. Koric A, Singh B, VanDerslice JA, Stanford JB, Rogers CR, Egan DT, Agyemang DO, Schliep K (2021). Polycystic ovary syndrome and postpartum depression symptoms: a population-based cohort study. Am J Obstet Gynecol, 224(6), 591.e1-591.e12.
  6. Ocier K, Abdelaziz S, Kim S, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Porucznik CA, Shoaf K, Stanford JB, Lee CJ, Hashibe M (2021). Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin's lymphoma survivors. Cancer Med, 10(12), 4117-4126.
  7. Qeadan F, Mensah NA, Tingey B, Stanford JB (2021). The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. BMC Pregnancy Childbirth, 21(1), 305.
  8. Hu Q, Chang CP, Rowe K, Snyder J, Deshmukh V, Newman M, Fraser A, Smith K, Gren LH, Porucznik C, Stanford JB, Gaffney D, Henry NL, Lopez I, Hashibe M (2021). Disparities in Cardiovascular Disease Risk Among Hispanic Breast Cancer Survivors in a Population-Based Cohort. JNCI Cancer Spectr, 5(2), pkab016.
  9. Baayd J, Simonsen SE, Stanford JB, Willis SK, Frost CJ (2021). Identifying barriers to accessing skilled maternal health care in rural Morocco. Afr J Reprod Health, 25(1), 20-28.
  10. Dunlop AL, Essalmi AG, Alvalos L, Breton C, Camargo CA, Cowell WJ, Dabelea D, Dager SR, Duarte C, Elliott A, Fichorova R, Gern J, Hedderson MM, Thepaksorn EH, Huddleston K, Karagas MR, Kleinman K, Leve L, Li X, Li Y, Litonjua A, Ludena-Rodriguez Y, Madan JC, Nino JM, McEvoy C, OConnor TG, Padula AM, Paneth N, Perera F, Sathyanarayana S, Schmidt RJ, Schultz RT, Snowden J, Stanford JB, Trasande L, Volk HE, Wheaton W, Wright RJ, McGrath M, program collaborators for Environmental Influences on Child Health Outcomes (2021). Racial and geographic variation in effects of maternal education and neighborhood-level measures of socioeconomic status on gestational age at birth: Findings from the ECHO cohorts. PLoS One, 16(1), e0245064.
  11. DeVilbiss EA, Stanford JB, Mumford SL, Sjaarda LA, Kim K, Zolton JR, Perkins NJ, Schisterman EF (2020). Sporadic anovulation is not an important determinant of becoming pregnant and time to pregnancy among eumenorrheic women: A simulation study. Paediatr Perinat Epidemiol, 35(1), 143-152.
  12. Stanford JB, Willis SK, Hatch EE, Rothman KJ, Wise LA (2020). Fecundability in relation to use of mobile computing apps to track the menstrual cycle. Hum Reprod, 35(10), 2245-2252.
  13. Stanford JB, Hansen JL, Willis SK, Hu N, Thomas A (2017). Peri-implantation intercourse does not lower fecundability. Hum Reprod, 35(9), 2107-2112.
  14. Najmabadi S, Schliep KC, Simonsen SE, Porucznik CA, Egger MJ, Stanford JB (2020). Menstrual bleeding, cycle length, and follicular and luteal phase lengths in women without known subfertility: A pooled analysis of three cohorts. Paediatr Perinat Epidemiol, 34(3), 318-327.
  15. Chang CP, Chen Y, Blackburn B, Abdelaziz S, Rowe K, Snyder J, Dodson M, Deshmukh V, Newman M, Stanford JB, Porucznik CA, Ose J, Fraser A, Smith K, Doherty J, Gaffney D, Hashibe M (2020). Genitourinary disease risks among ovarian cancer survivors in a population-based cohort study. Gynecol Oncol, 157(2), 529-535.
  16. Stanford JB, Schliep KC, Chang CP, OSullivan JP, Porucznik CA (2019). Comparison of woman-picked, expert-picked, and computer-picked Peak Day of cervical mucus with blinded urine luteinising hormone surge for concurrent identification of ovulation. Paediatr Perinat Epidemiol, 34(2), 105-113.
  17. Johnson S, Stanford JB, Warren G, Bond S, Bench-Capon S, Zinaman MJ (2019). Increased Likelihood of Pregnancy Using an App-Connected Ovulation Test System: A Randomized Controlled Trial. J Womens Health (Larchmt), 29(1), 84-90.
  18. Byun J, Peterson CM, Backonja U, Taylor RN, Stanford JB, Allen-Brady KL, Smith KR, Louis GMB, Schliep KC (2020). Adiposity and Endometriosis Severity and Typology. J Minim Invasive Gynecol, 27(7), 1516-1523.
  19. Hu Q, Lee J, Nelson J, Harris M, Ess RH, Rogers CR, Sanders J, VanDerslice J, Stanford JB, Schliep KC (2020). The association between preconception body mass index and subfertility among Hispanic and non-Hispanic women: A cross-sectional study from Utah's Pregnancy Risk Assessment Monitoring System survey (2012-2015). Utah Womens Health Rev, 2020.
  20. Bliss JC, Mensah NA, Rogers CR, Stanford JB, VanDerslice J, Schliep KC (2020). The Baby-Friendly Hospital Initiative (BFHI): An Early Cross-Sectional Analysis of PRAMS Phase 8 Data on Hospital Practices and Breastfeeding Outcomes in Utah and Wyoming. Utah Womens Health Rev, 2020.
  21. Pollard SH, Cox KJ, Blackburn BE, Wilkins DG, Carrell DT, Stanford JB, Porucznik CA (2019). Male exposure to bisphenol A (BPA) and semen quality in the Home Observation of Periconceptional Exposures (HOPE) cohort. Reprod Toxicol, 90, 82-87.
  22. Park J, Stanford JB, Porucznik CA, Christensen K, Schliep KC (2019). Daily perceived stress and time to pregnancy: A prospective cohort study of women trying to conceive. Psychoneuroendocrinology, 110, 104446.
  23. Yeum D, Ju S, Cox KJ, Zhang Y, Stanford JB, Porucznik CA (2019). Association between peri-conceptional bisphenol A exposure in women and men and time to pregnancy-The HOPE study. Paediatr Perinat Epidemiol, 33(6), 397-404.
  24. Harville EW, Mishra GD, Yeung E, Mumford SL, Schisterman EF, Jukic AM, Hatch EE, Mikkelsen EM, Jiang H, Ehrenthal DB, Porucznik CA, Stanford JB, Wen SW, Harvey A, Symons Downs D, Yajnik C, Santillan D, Santillan M, McElrath TF, Woo JG, Urbina EM, Chavarro JE, Sotres-Alvarez D, Bazzano L, Zhang J, Steiner A, Gunderson EP, Wise LA (2019). The Preconception Period analysis of Risks and Exposures Influencing health and Development (PrePARED) consortium. Paediatr Perinat Epidemiol, 33(6), 490-502.
  25. Stanford JB, Willis SK, Hatch EE, Rothman KJ, Wise LA (2019). Fecundability in relation to use of fertility awareness indicators in a North American preconception cohort study. Fertil Steril, 112(5), 892-899.
  26. Cox KJ, Stanford JB, Blackburn BE, Porucznik CA (2019). Compliance with daily, home-based collection of urinary biospecimens in a prospective, preconception cohort. Environ Epidemiol, 3(3), e050.
  27. Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Al-Sarray A, Werner TL, Setiawan VW, Hashibe M (2017). Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study. J Natl Cancer Inst, 110(12), 1342-1351.
  28. Soisson S, Ganz PA, Gaffney D, Rowe K, Snyder J, Wan Y, Deshmukh V, Newman M, Fraser A, Smith K, Herget K, Hanson HA, Wu YP, Stanford J, Werner TL, Setiawan VW, Hashibe M (2017). Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. Gynecol Oncol, 148(3), 499-506.
  29. Rainey E, Simonsen S, Stanford J, Shoaf K, Baayd J (2017). Utah obstetricians' opinions of planned home birth and conflicting NICE/ACOG guidelines: A qualitative study. Birth, 44(2), 137-144.
  30. Luderer U, Li T, Fine JP, Hamman RF, Stanford JB, Baker D (2017). Transitions in pregnancy planning in women recruited for a large prospective cohort study. Hum Reprod, 32(6), 1325-1333.
  31. Pugh SJ, Schisterman EF, Browne RW, Lynch AM, Mumford SL, Perkins NJ, Silver R, Sjaarda L, Stanford JB, Wactawski-Wende J, Wilcox B, Grantz KL (2017). Preconception maternal lipoprotein levels in relation to fecundability. Hum Reprod, 32(5), 1055-1063.
  32. Sjaarda LA, Radin RG, Silver RM, Mitchell E, Mumford SL, Wilcox B, Galai N, Perkins NJ, Wactawski-Wende J, Stanford JB, Schisterman EF (2017). Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial. J Clin Endocrinol Metab, 102(5), 1495-1504.
  33. Boltz MW, Sanders JN, Simonsen SE, Stanford JB (2017). Fertility Treatment, Use of in Vitro Fertilization, and Time to Live Birth Based on Initial Provider Type. J Am Board Fam Med, 30(2), 230-238.
  34. Schliep KC, Mumford SL, Johnstone EB, Peterson CM, Sharp HT, Stanford JB, Chen Z, Backonja U, Wallace ME, Buck Louis GM (2016). Sexual and physical abuse and gynecologic disorders. Hum Reprod, 31(8), 1904-12.
  35. Wesselink AK, Wise LA, Hatch EE, Rothman KJ, Mikkelsen EM, Stanford JB, McKinnon CJ, Mahalingaiah S (2016). Menstrual cycle characteristics and fecundability in a North American preconception cohort. Ann Epidemiol, 26(7), 482-487.e1.
  36. Stanford JB, Sanders JN, Simonsen SE, Hammoud A, Gibson M, Smith KR (2016). Methods for a Retrospective Population-based and Clinic-based Subfertility Cohort Study: the Fertility Experiences Study. Paediatr Perinat Epidemiol, 30(4), 397-407.
  37. Porucznik CA, Cox KJ, Schliep KC, Wilkins DG, Stanford JB (2016). The Home Observation of Periconceptional Exposures (HOPE) study, a prospective cohort: aims, design, recruitment and compliance. Environ Health, 15(1), 67.
  38. Stanford JB, Simonsen SE, Baksh L (2015). Fertility treatments and adverse perinatal outcomes in a population-based sampling of births in Florida, Maryland, and Utah: a cross-sectional study. BJOG, 123(5), 718-29.
  39. Zarek SM, Mitchell EM, Sjaarda LA, Mumford SL, Silver RM, Stanford JB, Galai N, Schliep KC, Radin RG, Plowden TC, DeCherney AH, Schisterman EF (2016). Antimüllerian hormone and pregnancy loss from the Effects of Aspirin in Gestation and Reproduction trial. Fertil Steril, 105(4), 946-952.e2.
  40. Stanford JB (2016). Population, Reproductive, and Sexual Health: Data Are Essential Where Disciplines Meet and Ideologies Conflict. Front Public Health, 4, 27.
  41. Jenkins TG, Aston KI, Meyer TD, Hotaling JM, Shamsi MB, Johnstone EB, Cox KJ, Stanford JB, Porucznik CA, Carrell DT (2016). Decreased fecundity and sperm DNA methylation patterns. Fertil Steril, 105(1), 51-7.e1-3.
  42. Thomas FS, Stanford JB, Sanders JN, Gurtcheff SE, Gibson M, Porucznik CA, Simonsen SE (2015). Development and initial validation of a fertility experiences questionnaire. Reprod Health, 12, 62.
  43. Stanford JB (2015). Revisiting the fertile window. Fertil Steril, 103(5), 1152-3.
  44. Lesher LL, Matyas RA, Sjaarda LA, Newman SL, Silver RM, Galai N, Hovey KM, Wactawski-Wende J, Emerick L, Lynch AM, Mead B, Townsend JM, Perkins NJ, Mumford SL, Stanford J, Schisterman EF (2015). Recruitment for longitudinal, randomised pregnancy trials initiated preconception: lessons from the effects of aspirin in gestation and reproduction trial. Paediatr Perinat Epidemiol, 29(2), 162-7.
  45. Koch E, Chireau M, Pliego F, Stanford J, Haddad S, Calhoun B, Aracena P, Bravo M, Gatica S, Thorp J (2015). Abortion legislation, maternal healthcare, fertility, female literacy, sanitation, violence against women and maternal deaths: a natural experiment in 32 Mexican states. BMJ Open, 5(2), e006013.
  46. Stanford JB, Smith KR, Varner MW (2014). Impact of instruction in the Creighton model fertilitycare system on time to pregnancy in couples of proven fecundity: results of a randomised trial. Paediatr Perinat Epidemiol, 28(5), 391-9.
  47. Schliep KC, Mumford SL, Hammoud AO, Stanford JB, Kissell KA, Sjaarda LA, Perkins NJ, Ahrens KA, Wactawski-Wende J, Mendola P, Schisterman EF (2014). Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria. J Clin Endocrinol Metab, 99(6), E1007-14.
  48. Sanders J, Simonsen S, Porucznik CA, Baksh L, Stanford JB (2014). Use of fertility treatments in relation to the duration of pregnancy attempt among women who were trying to become pregnant and experienced a live birth. Matern Child Health J, 18(1), 258-267.
  49. Pollack AZ, Louis GM, Chen Z, Peterson CM, Sundaram R, Croughan MS, Sun L, Hediger ML, Stanford JB, Varner MW, Palmer CD, Steuerwald AJ, Parsons PJ (2013). Trace elements and endometriosis: the ENDO study. Reprod Toxicol, 42, 41-8.
  50. Schisterman EF, Silver RM, Perkins NJ, Mumford SL, Whitcomb BW, Stanford JB, Lesher LL, Faraggi D, Wactawski-Wende J, Browne RW, Townsend JM, White M, Lynch AM, Galai N (2013). A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics. Paediatr Perinat Epidemiol, 27(6), 598-609.
  51. Evans-Hoeker E, Pritchard DA, Long DL, Herring AH, Stanford JB, Steiner AZ (2013). Cervical mucus monitoring prevalence and associated fecundability in women trying to conceive. Fertil Steril, 100(4), 1033-1038.e1.
  52. Peterson CM, Johnstone EB, Hammoud AO, Stanford JB, Varner MW, Kennedy A, Chen Z, Sun L, Fujimoto VY, Hediger ML, Buck Louis GM, ENDO Study Working Group (2013). Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study. Am J Obstet Gynecol, 208(6), 451.e1-11.
  53. Simonsen SE, Lyon JL, Stanford JB, Porucznik CA, Esplin MS, Varner MW (2013). Risk factors for recurrent preterm birth in multiparous Utah women: a historical cohort study. BJOG, 120(7), 863-72.
  54. Stanford JB, Martin JC, Gibson M, Birdsall E, Brixner DI (2013). Use of clomiphene citrate in the University of Utah Community Clinics. J Reprod Med, 58(5-6), 229-33.
  55. Schliep KC, Schisterman EF, Mumford SL, Perkins NJ, Ye A, Pollack AZ, Zhang C, Porucznik CA, VanDerslice JA, Stanford JB, Wactawski-Wende J (2013). Validation of different instruments for caffeine measurement among premenopausal women in the BioCycle study. Am J Epidemiol, 177(7), 690-9.
  56. Schliep KC, Schisterman EF, Mumford SL, Pollack AZ, Perkins NJ, Ye A, Zhang CJ, Stanford JB, Porucznik CA, Hammoud AO, Wactawski-Wende J (2013). Energy-containing beverages: reproductive hormones and ovarian function in the BioCycle Study. Am J Clin Nutr, 97(3), 621-30.
  57. Stanford JB, Smith KR (2013). Marital fertility and income: moderating effects of the Church of Jesus Christ of Latter-day Saints religion in Utah. J Biosoc Sci, 45(2), 239-48.
  58. Stone MB, Stanford JB, Lyon JL, VanDerslice JA, Alder SC (2013). Childhood thyroid radioiodine exposure and subsequent infertility in the intermountain fallout cohort. Environ Health Perspect, 121(1), 79-84.
  59. Hammoud AO, Meikle AW, Peterson CM, Stanford J, Gibson M, Carrell DT (2012). Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian J Androl, 14(6), 855-9.
  60. Thoma ME, Hediger ML, Sundaram R, Stanford JB, Peterson CM, Croughan MS, Chen Z, Buck Louis GM, ENDO Study Working Group (2012). Comparing apples and pears: women's perceptions of their body size and shape. J Womens Health (Larchmt), 21(10), 1074-81.
  61. Cai B, Dunson DB, Stanford JB (Fall 2010). Dynamic model for multivariate markers of fecundability. Biometrics, 66(3), 905-13.
  62. Cai B, Dunson DB, Stanford JB (2009). Dynamic model for multivariate markers of fecundability. Biometrics, 66(3), 905-13.
  63. Greenwood JL, Joy EA, Stanford JB (2010). The Physical Activity Vital Sign: a primary care tool to guide counseling for obesity. J Phys Act Health, 7(5), 571-6.
  64. Stanford JB, Mikolajczyk RT, Lynch CD, Simonsen SE (2010). Cumulative pregnancy probabilities among couples with subfertility: effects of varying treatments. Fertil Steril, 93(7), 2175-81.
  65. Crookston BT, Alder SC, Boakye I, Merrill RM, Amuasi JH, Porucznik CA, Stanford JB, Dickerson TT, Dearden KA, Hale DC, Sylverken J, Snow BS, Osei-Akoto A, Ansong D (2010). Exploring the relationship between chronic undernutrition and asymptomatic malaria in Ghanaian children. Malar J, 9, 39.
  66. Hammoud AO, Gibson M, Stanford J, White G, Carrell DT, Peterson M (2008). In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors. Fertil Steril, 91(5), 1630-5.
  67. Mikolajczyk RT, Stanford JB, Ecochard R (2008). Multilevel model to assess sources of variation in follicular growth close to the time of ovulation in women with normal fertility: a multicenter observational study. Reprod Biol Endocrinol, 6, 61.
  68. Greenwood JL, Murtaugh MA, Omura EM, Alder SC, Stanford JB (2008). Creating a clinical screening questionnaire for eating behaviors associated with overweight and obesity. J Am Board Fam Med, 21(6), 539-48.
  69. Stanford JB, Parnell TA, Boyle PC (2008). Outcomes from treatment of infertility with natural procreative technology in an Irish general practice. J Am Board Fam Med, 21(5), 375-84.
  70. Greenwood JL, Stanford JB (2008). Preventing or improving obesity by addressing specific eating patterns. J Am Board Fam Med, 21(2), 135-40.
  71. Mikolajczyk RT, Stanford JB (2007). Levonorgestrel emergency contraception: a joint analysis of effectiveness and mechanism of action. Fertil Steril, 88(3), 565-71.
  72. de Irala J, Lopez del Burgo C, Lopez de Fez CM, Arredondo J, Mikolajczyk RT, Stanford JB (2007). Women's attitudes towards mechanisms of action of family planning methods: survey in primary health centres in Pamplona, Spain. BMC Womens Health, 7, 10.
  73. Stanford JB, Dunson DB (2007). Effects of sexual intercourse patterns in time to pregnancy studies. Am J Epidemiol, 165(9), 1088-95.
  74. Selevan SG, Stanford JB (2006). Workshop recommendations for the preconception cohort of the National Children's Study. Paediatr Perinat Epidemiol, 20 Suppl 1, 60-5.
  75. Mikolajczyk RT, Stanford JB (2006). Measuring fecundity with standardised estimates of expected pregnancies. Paediatr Perinat Epidemiol, 20 Suppl 1, 43-50.
  76. Snow M, White GL Jr, Alder SC, Stanford JB (2006). Mentor's hand hygiene practices influence student's hand hygiene rates. Am J Infect Control, 34(1), 18-24.
  77. Dye HM, Stanford JB, Alder SC, Kim HS, Murphy PA (2005). Women and postfertilization effects of birth control: consistency of beliefs, intentions and reported use. BMC Womens Health, 5, 11.
  78. Mikolajczyk RT, Stanford JB (2005). A new method for estimating the effectiveness of emergency contraception that accounts for variation in timing of ovulation and previous cycle length. Fertil Steril, 83(6), 1764-70.
  79. Chen C, Wang X, Wang L, Yang F, Tang G, Xing H, Ryan L, Lasley B, Overstreet JW, Stanford JB, Xu X (2005). Effect of environmental tobacco smoke on levels of urinary hormone markers. Environ Health Perspect, 113(4), 412-7.
  80. Hobson WL, Avant-Mier R, Cochella S, Van Hala S, Stanford J, Alder SC, Croskell SE (2005). Caring for the underserved: using patient and physician focus groups to inform curriculum development. Ambul Pediatr, 5(2), 90-5.
  81. Dunson DB, Stanford JB (2005). Bayesian inferences on predictors of conception probabilities. Biometrics, 61(1), 126-33.
  82. Stanford JB, Mikolajczyk RT (2005). Methodological review of the effectiveness of emergency contraception. Curr Womens Health Rev, 1(2), 119-129.
  83. Hobson SL, Avant-Mier R, Cochella S, Van Hala S, Stanford J, Alder SC, Croskell SE (2005). Caring for the underserved. Using patient and physician focus groups to inform curriculum development. Ambul Pediatr, 5, 90-5.
  84. Bigelow JL, Dunson DB, Stanford JB, Ecochard R, Gnoth C, Colombo B (2004). Mucus observations in the fertile window: a better predictor of conception than timing of intercourse. Hum Reprod, 19(4), 889-92.
  85. Tingen C, Stanford JB, Dunson DB (2004). Methodologic and statistical approaches to studying human fertility and environmental exposure. Environ Health Perspect, 112(1), 87-93.
  86. Buck GM, Lynch CD, Stanford JB, Sweeney AM, Schieve LA, Rockett JC, Selevan SG, Schrader SM (2004). Prospective pregnancy study designs for assessing reproductive and developmental toxicants. Environ Health Perspect, 112(1), 79-86.
  87. Daniels M, Merrill RM, Lyon JL, Stanford JB, White GL Jr (2004). Associations between breast cancer risk factors and religious practices in Utah. Prev Med, 38(1), 28-38.
  88. Stanford JB, Smith KR, Dunson DB (2003). Vulvar mucus observations and the probability of pregnancy. Obstet Gynecol, 101(6), 1285-93.
  89. Mikolajczyk RT, Stanford JB, Rauchfuss M (2003). Factors influencing the choice to use modern natural family planning. Contraception, 67(4), 253-8.
  90. Stanford JB, Galbraith A, Payne JG (2003). Utah couples' potential use of natural family planning. 9, 40-5.
  91. Stanford JB, Mikolajczyk RT (2002). Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects. Am J Obstet Gynecol, 187(6), 1699-708.
  92. Stanford JB, White GL, Hatasaka H (2002). Timing intercourse to achieve pregnancy: current evidence. Obstet Gynecol, 100(6), 1333-41.
  93. Kahlenborn C, Stanford JB, Larimore WL (2002). Postfertilization effect of hormonal emergency contraception. Ann Pharmacother, 36(3), 465-70.
  94. Nielsen MS, Barton SD, Hatasaka HH, Stanford JB (2001). Comparison of several one-step home urinary luteinizing hormone detection test kits to OvuQuick. Fertil Steril, 76(2), 384-7.
  95. Fehring RJ, Hanson L, Stanford JB (2001). Nurse-midwives' knowledge and promotion of lactational amenorrhea and other natural family-planning methods for child spacing. J Midwifery Womens Health, 46(2), 68-73.
  96. Stanford JB, Hobbs R, Jameson P, DeWitt MJ, Fischer RC (2000). Defining dimensions of pregnancy intendedness. Matern Child Health J, 4(3), 183-9.
  97. Stanford JB, Larimore W (2000). Informed consent for postfertilization effects of hormonal and surgical forms of birth control for women. Arch Fam Med, 9(8), 690-1.
  98. Larimore WL, Stanford JB (2000). Postfertilization effects of oral contraceptives and their relationship to informed consent. Arch Fam Med, 9(2), 126-33.
  99. Stanford JB, Smith KR (2000). Characteristics of women associated with continuing instruction in the Creighton Model Fertility Care System. Contraception, 61(2), 121-9.
  100. Stanford JB, Thurman PB, Lemaire JC (1999). Physicians' knowledge and practices regarding natural family planning. Obstet Gynecol, 94(5 Pt 1), 672-8.
  101. Trussell J, Vaughan B, Stanford J (1999). Are all contraceptive failures unintended pregnancies? Evidence from the 1995 National Survey of Family Growth. Fam Plann Perspect, 31(5), 246-7, 260.
  102. Howard MP, Stanford JB (1999). Pregnancy probabilities during use of the Creighton Model Fertility Care System. Arch Fam Med, 8(5), 391-402.
  103. Fischer RC, Stanford JB, Jameson P, DeWitt MJ (1999). Exploring the concepts of intended, planned, and wanted pregnancy. J Fam Pract, 48(2), 117-22.
  104. Hilgers TW, Stanford JB (1998). Creighton Model NaProEducation Technology for avoiding pregnancy. Use effectiveness. J Reprod Med, 43(6), 495-502.
  105. Stanford JB, Lemaire JC, Thurman PB (1998). Women's interest in natural family planning. J Fam Pract, 46(1), 65-71.
  106. Campbell JD, Mitchell P, Stanford JB, Ewigman BG (1995). Validating a model developed to predict prenatal care utilization. J Fam Pract, 41(5), 457-64.
  107. Stanford JB, Lemaire JC, Fox A (1994). Interest in natural family planning among female family practice patients. Fam Pract Res J, 14(3), 237-49.

Review

  1. Stroesser K, Stanford JB (Fall 2010). Polycystic ovarian syndrome. [Review]. 13(10), 9.
  2. Campbell JD, Stanford J, Ewigman B (1996). The social pregnancy interaction model: conceptualizing cognitive, social and cultural barriers to prenatal care. [Review]. Appl Behav Sci Rev, 4(1), 81-97.

Book Chapter

  1. Stanford JB (2004). Measuring effectiveness and pregnancy rates of the Creighton Model System. In Hilgers TW (Ed.). Omaha, NE: Pope Paul VI Institute Press.
  2. Stanford JB (2004). Fecundity and mucus cycle score in couples using the Creighton Model System. In Hilgers TW (Ed.). Omaha, NE: Pope Paul VI Institute Press.
  3. Hilgers TW, Stanford JB (2004). Achieving-related pregnancy rate and its natural adaptability. In Hilgers TW (Ed.). Omaha, NE: Pope Paul VI Institute Press.
  4. Stanford JB, Hobbins D (2001). Preconception Risk Assessment. In Ratcliffe SD, Baxley L, Byrd JE, Sakornbut EL (Eds.), Family Practice Obstetrics (2nd Edition, pp. 1-13). St. Louis, MO: Hanley & Belfus, Mosby.

Commentary

  1. Stanford JB (2019). Big data meets the menstrual cycle. Fertil Steril, 112(3), 464-465.
  2. Stanford JB (2012). Comment on Kim et al., "Flexible Bayesian Fecundity Models". Clin Pharmacol Ther, 7(4), 805-8.
  3. Stanford JB (2008). Emergency contraception: overestimated effectiveness and questionable expectations. Clin Pharmacol Ther, 83(1), 19-21.
  4. Stanford JB, Dunson DB (2006). Foreword. Expanding Methodologies for Capturing Day-Specific Probabilities of Conception. Paediatr Perinat Epidemiol, 20 Suppl 1, 1-2.

Letter

  1. Stanford JB, James G, McLindon LA (2020). Is ART utilization the best indicator of access to fertility care? [Letter to the editor]. Reprod Biomed Online, 41(6), 1157.
  2. Carpentier PA, Stanford JB, Boyle PC (2016). Progesterone in Women with Recurrent Miscarriages. [Letter to the editor]. N Engl J Med, 374(9), 894.
  3. Lopez-del Burgo C, Mikolajczyk RT, Stanford JB (2011). Emergency contraception: an unresolved issue. [Letter to the editor]. Contraception, 83(2), 187; author reply 187-8.
  4. Stanford JB, Mikolajczyk RT, Dunson DB (2010). Are Chinese people really more fertile? [Letter to the editor]. Fertil Steril, 94(3), e58.
  5. Stanford JB, Parnell TA, Boyle PC (2009). Response: Re: Outcomes from treatment of infertility with natural procreative technology in an Irish general practice [Letter to the editor]. J Am Board Fam Med, 2009(22), 95-96.
  6. Mikolajczyk RT, Stanford JB (2007). The empirical and ethical questions of induced versus natural losses of preimplantation embryos. [Letter to the editor]. Contraception, 76(3), 256.
  7. Stanford JB (2006). The biology of human sex differences. [Letter to the editor]. N Engl J Med, 355(1), 98; author reply 98.
  8. Stanford JB, Mikolajczyk RT (2006). Emergency contraception. [Letter to the editor]. Pediatrics, 117(4), 1448; author reply 1450.
  9. Mikolajczyk RT, Stanford JB (2006). Effectiveness of LNG EC not fully explained by ovulatory dysfunction. [Letter to the editor]. Contraception, 73(1), 107; author reply 108-9.
  10. Stanford JB, Larimore WL (2005). Description of emergency contraception in the media. [Letter to the editor]. Contraception, 72(5), 394-5; author reply 396-7.
  11. Stanford JB (2005). Mormon bioethics. [Letter to the editor]. First Things, (156), 8.
  12. Stanford JB, Cochella SW (2005). More on family medicine research. [Letter to the editor]. Fam Med, 37(9), 612; author reply 612-3.
  13. Larimore WL, Stanford JB, Kahlenborn C (2004). Does pregnancy begin at fertilization? [Letter to the editor]. Fam Med, 36(10), 690-1; author reply 691.
  14. Stanford JB, Hager WD, Crockett SA (2004). The FDA, politics, and plan B. [Letter to the editor]. N Engl J Med, 350(23), 2413-4; author reply 2413-4.
  15. Mikolajczyk RT, Frank-Herrmann P, Freundl G, Stanford JB (2004). More than one fertile ovulation per cycle? [Letter to the editor]. Fertil Steril, 81(3), 728-9.
  16. Mikolajczyk RT, Stanford JB (2004). Efficacy of postcoital contraception [Letter to the editor]. Fertil Steril, 81(6), 1725.
  17. Mikolajczyk RT, Stanford JB (2004). Validity of methods used to estimate the effectiveness of emergency contraception [Letter to the editor]. Biom J, 46(Supplement), 61.
  18. Stanford JB, Dunson DB, Tingen C (2004). Studying human fertility [Letter to the editor]. Environ Health Perspect, 112(11).
  19. Stanford JB (2004). The visit before the morning after: barriers to preprescribing emergency contraception [response] [Letter to the editor]. Ann Fam Med.
  20. Mikolajczyk RT, Stanford JB (2003). Estimating the efficacy of emergency contraception. [Letter to the editor]. Fertil Steril, 80(6), 1536-7; author reply 1537.
  21. Mikolajczyk R, Spinnato JA, Stanford JB, Mikolajczyk R, Spinnato JA, Stanford JB (2003). Uncertainty in estimating the day of ovulation causes overestimation of the role of ovulation disturbance on the effectiveness of the Yuzpe method of emergency contraception. [Letter to the editor]. Contraception, 68(1), 69-70; author reply 70-1.
  22. Mikolajczyk RT, Stanford JB (2003). False risk attribution results in misleading assessment of the relationship between suppression of ovulation and the effectiveness of the Yuzpe regimen for emergency contraception. [Letter to the editor]. Contraception, 67(4), 333-5; author reply 335-7.
  23. Larimore WL, Stanford JB (2000). Ectopic pregnancy with oral contraceptive use has been overlooked. [Letter to the editor]. BMJ, 321(7258), 450.
  24. Hilgers TW, Stanford JB (1999). Analyzing contraceptive failure [Letter to the editor]. J Reprod Med, 44, 480-1.
  25. Stanford JB (1997). Measuring contraceptive effectiveness: a conceptual framework. [Letter to the editor]. Obstet Gynecol, 89(1), 157-8.
  26. Stanford JB, Weed SE, Toffler WL (1994). Second-trimester abortion. [Letter to the editor]. N Engl J Med, 331(25), 1715-6.
  27. Bretzman MC, Stanford JB (1994). Condoms, IUDs, counseling and natural family planning. [Letter to the editor]. Am Fam Physician, 50(4), 766, 768.
  28. Stanford JB (1994). How effective is natural family planning? [Letter to the editor]. 28(10), 8.
  29. Stanford JB (1993). More on condoms in school clinics [Letter to the editor]. Postgrad Med, 94(1), 40.
  30. Stanford JB, Peyton E, Lee S, Kraus R (1992). Letting children observe deliveries. [Letter to the editor]. N Engl J Med, 326(16), 1085-6.

Video/Film/CD/Web/Podcast

  1. Stanford JB (2009). Video Interview: Natural Family Planning [Video]. Salt Lake City, UT: KUTV Healthy Living.

News Articles

Children, Adults Equally Vulnerable to Coronavirus Infection

Hormone Therapy and Fertility

University of Utah and Utah Families to Partner in a National Initiative to Study Children’s Health

The Impacts of Caffeine on Miscarriage

The Scope & Other Podcasts

  • Natural Approaches to Improve Fertility
  • Is a Natural Approach to Family Planning Right For You? 
  • Healthy & Safe Options for Treating Polycystic Ovarian Syndrome
  • How Unwanted Hair Can Be Related to Problems in Your Reproductive System
  • Severe Menstrual Pain? It Could Be Something Serious
  • Ask an Expert Ovulation
  • Ask an Expert Infertility
  • Ask an Expert Polycystic Ovarian Syndrome

Videos

Ask an Expert Polycystic Ovarian Syndrome

Ask an Expert Ovulation

Ask an Expert Infertility

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2022 University of Utah Health